Innogen · News · October 11, 2013

Innogen Weekly News Roundup (05/10/13 - 11/10/13)

Innogen Weekly News Roundup (05/10/13 - 11/10/13)

All the latest news from around the world on the life sciences and emerging technologies.

A weekly roundup of global news on topics, including: agriculture, the bioeconomy, food and energy security, genes and genomics, global health and development, healthcare, innovation systems, pharma, synthetic biology, science and technology.


In Defence of: GM Crops (Varsity)

Monsanto Buys The Climate Corporation, Brings Big Data to Agriculture (Environmental Leader)

Genetically Modified Sweet Corn Better For Environment, Safer for Farm Workers (Red Orbit)

Can Science and Technology Meet Global Food Production Needs? (The Fish Site)


Bioeconomy on track (The Star)

Biotechnology and advance marine processing fishing industry subsectors grow (FIS)

The Green economy is Europe’s ticket to the post-crisis world (EurActiv)


‘Designer baby’ patent raises ethical questions (ABC Science)

Improving the quality of clinical ethics consultants (Medical Xpress)

Genes & Genomics

How personal genomics is proving to be a popular tool in preventative healthcare (Economic Times)

Are we on the verge of an era of personalised medicine? Ten years on from the Human Genome Project. (the brain bank)

Ambitious U.K. genome project looks for industry input (FierceBiotechIT)

Global Development

Innovation challenges discussed at TWAS annual meeting (SciDevNet)

Social media, crisis mapping and the new frontier in disaster response (Guardian)

Global Health

Genetically modified bacterial treatment approach reduces or eliminates sleeping sickness (News Medical)

Cats May be the Key to Developing Effective Human HIV Vaccine (Science World Report)


Shutdown hits patients’ hopes for federally funded cancer drug trials (Reuters AlertNet)


Local pharma makers facing challenges (The News)

‘Pharma industry need to bring out advanced vaccines to meet threat of new epidemics’ (Pharma Biz)

Trial sponsors must reveal payments to investigators: Central Drug Standard Control Organisation (Times of India)

Clinical Trials Continue, but Only at a Crawl (New York Times)

Science & Technology

Innovation’s global nanotechnology divide causes controversy (Financial Times)

Edinburgh Science Triangle chairman on making capital a global leader (Daily Record)

Synthetic Biology

Glowing plants illuminate regulatory debate (News Courier)